16
Views
2
CrossRef citations to date
0
Altmetric
(RG) Obstetrics and Gynaecology

Contraceptive methods and risk factors of cardiovascular diseases in Tehranian women: Tehran Lipid and Glucose Study

, , &
Pages 1-6 | Published online: 06 Jul 2009

REFERENCES

  • Braunwald E. Shattuck lecture – cardiovascular medi- cine at the turn of the millennium: triumphs, concern, and opportunities. N Engl J Med 1997;337:1360–9
  • American Heart Association. Heart and Stroke Facts: 1995 Statistical Supplement. Dallas, TX: American Heart Association, 1994
  • Williams GH, Lilly LS, Seely EW. Thyroid disease. In Braunwald E, ed. Heart Disease, 5th edn. Philadelphia: W.B. Saunders, 1999:1890–3
  • Sarrafzadegan N, Najafian J. Priorities in cardiovascular prevention in Iran. Iranian Heart J 1998; 1(Suppl 1): 131–6
  • Farley TM, Meirik O, Poulter NR, Chang CL, Marmot MG. Oral contraceptives and thrombotic diseases: impact of new epidemiological studies. Contra- ception 1996;54:193–8
  • Lidegaard O, Edstrom B, Kreiner S. Oral contraceptives and venous thromboembolism. A case–control study. Contraception 1998;57:291–301
  • Diab KM, Zaki MM. Contraception in diabetic women: comparative metabolic study of Norplant, depot medroxyprogesterone acetate, low dose oral contraceptive pill and CT-380A. J Obstet Gynecol Res 2000;26:17–26
  • Winkler UH. Blood coagulation and oral contracep- tives. A critical review. Contraception 1998;57:203–9
  • World Health Organization. Cardiovascular Disease and Steroid Contraception 1998, Scientific Report No. 877
  • Azizi F, Rahmani M, Habib E, et al. Tehran Lipid and Glucose Study: rationale and design. Cardiovasc Dis Prevention 2000;3:242–7
  • Cerel-Suhl SL, Yeager BF. Update on oral contra- ceptive pills. Am Fam Physician 1999;60:2073–84
  • Petitti DB, Wingerd J, Pellegrin F, et al. Risk of vascular disease in women, smoking, oral contraceptives, non- contraceptive estrogens, and other factors. J Am Med Assoc 1979;242:1150–4
  • La Vecchia C, Franceschi S, Decarli A, et al. Risk factors for myocardial infarction in young women. Am J Epidemiol 1987;125:825–43
  • Croft P, Hannaford PC. Risk factors for acute myo- cardial infarction in women: evidence from the Royal College of General Practitioners oral contraception study. Br Med J 1989;298:165–8
  • Thorogood M, Mann J, Murphy M, et al. Is oral contraceptive use still associated with an increased risk of fatal myocardial infarction? Report of a case–control study. Br J Obstet Gynaecol 1991;98:1245–53
  • Salonen JT. Oral contraceptives, smoking and risk of myocardial infarction in young women. A longitudinal population study in eastern Finland. Acta Med Scand 1982;212:141–4
  • Shapiro S, Slone D, Rosenberg L, et al. Oral contra- ceptive use in relation to myocardial infarction. Lancet 1979;1:743–7
  • Rosenberg L, Hennekens CH, Rosner B, et al. Oral contraceptive use in relation to nonfatal myocardial infarction. Am J Epidemiol 1980;111:59–66
  • Rosenberg L, Palmer JR, Lesko SM, et al. Oral contra- cepive use and the risk of myocardial infarction. Am J Epidemiol 1990;131:1009–16
  • Kuhl H, Marz W, Jung-Hoffmann C, Weber J, Siekmeier R, Gross W. Effect on lipid metabolism of a biphasic desogestrel-containing oral contraceptive: divergent changes in apolipoprotein B and E and transi- tory decrease in Lp(a) levels. Contraception 1993;47:69–83
  • Karjalainen A, Heikkinen J, Savolainen MJ, Backstorm AC, Salinto M, Kesaniemi YA. Metabolic changes induced by peroral estrogen and transdermal oestradiol gel therapy. Br J Obstet Gynaecol 1997;104:38–43
  • Winkler UH, Holscher T, Schulte H, Zierleyn JP, Collet W, Schindler AE. Ethinylestradiol 20 versus 30 micrograms combined with 150 micrograms desogestrel: a large comparative study of the effects of two low-dose oral contraceptives on the haemostatic system. Gynecol Endocrinol 1996;10:265–71
  • Kasule J, Mbizvo M, Makuyana D, Mosona D. Evalua- tion of a combined oral contraceptive pill in black Zimbabwean women. Cent Afr J Med 1991;37:403–9
  • Wiseman RA. Absence of correlation between oral contraceptive usage and cardiovascular mortality. Int J Fertil 1984;29:198–208
  • Hirvonen E, Idanpaan Heikkila J. Cardiovascular death among women under 40 years of age using low- estrogen oral contraceptives and intrauterine devices in Finland from 1975 to 1984. Am J Obstet Gynecol 1990; 163:281–4
  • Thorogood M, Vessey MP. An epidemiologic survey of cardiovascular disease in women taking oral contra- ceptives. Am J Obstet Gynecol 1990;163:274–81
  • Stergachis A. Epidemiology of the noncontraceptive effects of oral contraceptives. Am J Obstet Gynecol 1992; 167:1165–70
  • Thorneycroft IH. Oral contraceptives and myocardial infarction. Am J Obstet Gynecol 1990;163:1393–7

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.